Cargando…
Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data
BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the S...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928804/ https://www.ncbi.nlm.nih.gov/pubmed/20691091 http://dx.doi.org/10.1186/1471-2105-11-416 |
_version_ | 1782185890698756096 |
---|---|
author | Beretta, Lorenzo Santaniello, Alessandro van Riel, Piet LCM Coenen, Marieke JH Scorza, Raffaella |
author_facet | Beretta, Lorenzo Santaniello, Alessandro van Riel, Piet LCM Coenen, Marieke JH Scorza, Raffaella |
author_sort | Beretta, Lorenzo |
collection | PubMed |
description | BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets. RESULTS: The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals. CONCLUSIONS: Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data. Availability: http://sourceforge.net/projects/sdrproject/ |
format | Text |
id | pubmed-2928804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29288042010-08-27 Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data Beretta, Lorenzo Santaniello, Alessandro van Riel, Piet LCM Coenen, Marieke JH Scorza, Raffaella BMC Bioinformatics Research Article BACKGROUND: Epistasis is recognized as a fundamental part of the genetic architecture of individuals. Several computational approaches have been developed to model gene-gene interactions in case-control studies, however, none of them is suitable for time-dependent analysis. Herein we introduce the Survival Dimensionality Reduction (SDR) algorithm, a non-parametric method specifically designed to detect epistasis in lifetime datasets. RESULTS: The algorithm requires neither specification about the underlying survival distribution nor about the underlying interaction model and proved satisfactorily powerful to detect a set of causative genes in synthetic epistatic lifetime datasets with a limited number of samples and high degree of right-censorship (up to 70%). The SDR method was then applied to a series of 386 Dutch patients with active rheumatoid arthritis that were treated with anti-TNF biological agents. Among a set of 39 candidate genes, none of which showed a detectable marginal effect on anti-TNF responses, the SDR algorithm did find that the rs1801274 SNP in the FcγRIIa gene and the rs10954213 SNP in the IRF5 gene non-linearly interact to predict clinical remission after anti-TNF biologicals. CONCLUSIONS: Simulation studies and application in a real-world setting support the capability of the SDR algorithm to model epistatic interactions in candidate-genes studies in presence of right-censored data. Availability: http://sourceforge.net/projects/sdrproject/ BioMed Central 2010-08-06 /pmc/articles/PMC2928804/ /pubmed/20691091 http://dx.doi.org/10.1186/1471-2105-11-416 Text en Copyright ©2010 Beretta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Beretta, Lorenzo Santaniello, Alessandro van Riel, Piet LCM Coenen, Marieke JH Scorza, Raffaella Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title | Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_full | Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_fullStr | Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_full_unstemmed | Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_short | Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
title_sort | survival dimensionality reduction (sdr): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928804/ https://www.ncbi.nlm.nih.gov/pubmed/20691091 http://dx.doi.org/10.1186/1471-2105-11-416 |
work_keys_str_mv | AT berettalorenzo survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT santanielloalessandro survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT vanrielpietlcm survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT coenenmariekejh survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata AT scorzaraffaella survivaldimensionalityreductionsdrdevelopmentandclinicalapplicationofaninnovativeapproachtodetectepistasisinpresenceofrightcensoreddata |